Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

NAFLD

Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes

Shannon CE, Ní Chathail MB, Mullin SM, Meehan A, McGillicuddy FC, Roche HM. Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes Rev Endocr Metab Disord
NAFLD

Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Hall RL, George ES, Tierney AC, Reddy AJ. Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis Adv Nutr
NAFLD

Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis

Ismaiel A, Hosiny BE, Ismaiel M, Leucuta DC, Popa SL, Catana CS, Dumitrascu DL. Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis Clin Res Hepatol Gastroenterol
NAFLD

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

Chen Y, Wang W, Morgan MP, Robson T, Annett S. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets Front Endocrinol (Lausanne)
NAFLD

Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes

Shannon CE, Ní Chathail MB, Mullin SM, Meehan A, McGillicuddy FC, Roche HM. Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes Rev Endocr Metab Disord
NAFLD

Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults

I. Cantero; M. Elorz; I. Abete; B. A. Marin; J. I. Herrero; J. I. Monreal; A. Benito; J. Quiroga; A. Martínez; M. P. Huarte; J. I. Uriz-Otano; J. A. Tur; J. Kearney; J. A. Martinez; M. A. Zulet Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults Int J Med Sci
Insulin Resistance & Diabetes NAFLD

UCP1 governs liver extracellular succinate and inflammatory pathogenesis

E. L. Mills; C. Harmon; M. P. Jedrychowski; H. Xiao; R. Garrity; N. V. Tran; G. A. Bradshaw; A. Fu; J. Szpyt; A. Reddy; H. Prendeville; N. N. Danial; S. P. Gygi; L. Lynch; E. T. Chouchani UCP1 governs liver extracellular succinate and inflammatory pathogenesis Nat Metab
Genetics NAFLD

Fatty liver disease in obese patients with COVID-19: a tale of two pandemics?

S. L. Yeoh; G. T. Flaherty Fatty liver disease in obese patients with COVID-19: a tale of two pandemics? Eur J Prev Cardiol
NAFLD

Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer

F. Donohoe; M. Wilkinson; E. Baxter; D. J. Brennan Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer Int J Mol Sci
NAFLD

Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device

J. Casella-Mariolo; L. Castagneto-Gissey; G. Angelini; A. Zoli; P. Marini; S. R. Bornstein; D. J. Pournaras; F. Rubino; C. W. le Roux; G. Mingrone; G. Casella Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device EBioMedicine
Insulin Resistance & Diabetes NAFLD

Older posts

Page1 Page2 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI